Document is current
Any future updates will be listed below
-
Authors
Thomsen, Camilla H. N.
Nørlev, Jannie T. D.
Hangaard, Stine
Jensen, Morten H.
Hejlesen, Ole
Cohen, Sarah R.
Kofoed-Enevoldsen, Allan
Kristensen, Sika N. S.
Aradóttir, Tinna B.
Kaas, Anne
Vestergaard, Peter
Kronborg, Thomas
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 28 October 2024
First Online: 8 November 2024
Declarations
:
: The trial protocol has been approved by the Danish Medical Research Ethics Committees (2313491). Any necessary modifications to the original trial protocol will require submission of a supplemental protocol to the Danish Medical Research Ethics Committees for approval. If the Danish Medical Research Ethics Committees determine that any modifications to the original protocol necessitate informing participants, they will be contacted by telephone.
: No personally identifiable information about individual participants will be disclosed. The authors do not anticipate the need for additional consent from participants for future studies using trial data. However, if such consent is unexpectedly required, participants will be contacted via mail.
: The principal investigator has no conflicts of interest. Several authors are present employees at Novo Nordisk A/S and/or hold company shares at Novo Nordisk A/S.
